Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product: Apo-Diltiazem CD
Active Ingredient: Diltiazem hydrochloride 120.12mg
Dosage Form: Modified release capsule
New Zealand Sponsor: Apotex NZ Limited
Manufacturer: Apotex Inc, Ontario, Canada
Product: Apo-Diltiazem CD
Active Ingredient: Diltiazem hydrochloride 180.1mg
Dosage Form: Modified release capsule
New Zealand Sponsor: Apotex NZ Limited
Manufacturer: Apotex Inc, Ontario, Canada
Product: Apo-Diltiazem CD
Active Ingredient: Diltiazem hydrochloride 240.1mg
Dosage Form: Modified release capsule
New Zealand Sponsor: Apotex NZ Limited
Manufacturer: Apotex Inc, Ontario, Canada
Product: Apo-Diltiazem CD
Active Ingredient: Diltiazem hydrochloride 300mg
Dosage Form: Modified release capsule
New Zealand Sponsor: Apotex NZ Limited
Manufacturer: Apotex Inc, Ontario, Canada
Product: Artelac Gel Tears
Active Ingredient: Carbomer 2mg/g
Dosage Form: Ophthalmic gel
New Zealand Sponsor: Bausch & Lomb (NZ) Limited
Manufacturer: Dr Gerhard Mann Chem-Pharm Fabrik GmbH, Berlin, Germany
Product: Artelac Gel Tears SDU
Active Ingredient: Carbomer 2mg/g
Dosage Form: Ophthalmic gel
New Zealand Sponsor: Bausch & Lomb (NZ) Limited
Manufacturer: Dr Gerhard Mann Chem-Pharm Fabrik GmbH, Berlin, Germany
Dated this 18th day of October 2012.
DR DON MACKIE, Chief Medical Officer, Clinical Leadership, Protection and Regulation Business Unit, Ministry of Health (pursuant to delegation given by the Minister of Health on 6 July 2001).